KLAS, a research firm that measures the performance of healthcare technology, recently released its “Clinical Decision Support 2011” report.

In the Disease Reference category, the report confirms the findings of an outcomes study conducted by Harvard researchers* which showed that hospital adoption of UpToDate is directly associated with lowered mortality, shortened lengths of stay and improved hospital quality.

KLAS:   UpToDate impacts quality and cost outcomes

According to the KLAS report:

·    “Surveillance tools (CareFocus, Sentri7) and the disease reference tool UpToDate were rated as the most impactful tools for on-the fly clinical decisions.”

·    “[UpToDate is the] physician-favorite evidence-based disease reference tool.”

·    “[UpToDate] has a reported high clinical impact and is the most used reference tool by physicians.”

In the Disease Reference category, UpToDate:

·        Has more clinical impact. 

·        Has the most positive impact on quality and cost outcomes.

·       Influences clinical decisions (UpToDate 7.7 vs. DynaMed 6.9).

·        Standardizes care (UpToDate 7.0 vs. DynaMed 6.8).

·        UpToDate is easier to deploy versus the other resources evaluated in the  survey.

·        UpToDate has better EMR integration (UpToDate 6.6 vs. DynaMed 6.4).

Source: KLAS Enterprises, LLC. © KLAS, “Clinical Decision Support 2011” report, Disease Reference category, November 2011, www.KLASresearch.com.

* Outcomes Study by Harvard Researchers (Isaac T, Zheng J, Ashish J. Use of UpToDate and Outcomes in US Hospitals,  J Hosp Med. 2011)

·       Abstract

·       More Info (includes a presentation deck and link to download full study)

  ·       Press release